Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Drug:  plerixafor
Find trials that include:  Any drugs shown
Results 1-7 of 7 for your search:
Start Over
Plerixafor after Radiation Therapy and Temozolomide in Treating Patients with Newly Diagnosed High Grade Glioma
Status: Active
Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 to 75
Trial IDs: BRN0023, NCI-2013-02012, 5136, NCT01977677
Stem Cell Collection with or without Bortezomib in Patients with Multiple Myeloma Undergoing Autologous Stem Cell Transplant
Status: Active
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 2015-IIT-BMT-MM-AutoSCT, NCI-2016-00429, STUDY00002857, NCT02703779
Gene Therapy for Fanconi Anemia
Status: Active
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: Not specified
Trial IDs: 2097.00, NCI-2011-00202, NCT01331018
Plerixafor and Bevacizumab in Treating Patients with Recurrent High-Grade Glioma
Status: Temporarily closed
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 10-329, NCI-2012-00149, MAMO0909-6, NCT01339039
HIV-Resistant Gene Modified Stem Cells and Chemotherapy in Treating Patients with Lymphoma with HIV Infection
Status: Active
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 to 66
Trial IDs: 2673.00, NCI-2014-02395, 2673, NCT02343666
Plerixafor in Increasing CD34+ Hematopoietic Progenitor Cells in Patients with Sickle Cell Disease
Status: Active
Phase: Phase I
Type: Biomarker/Laboratory analysis, Supportive care
Age: 18 to 65
Trial IDs: 13-229, NCI-2014-02024, NCT02193191
Access Program for Use of AMD3100 to Increase Peripheral Blood Stem Cells for Transplantation in Patients Who Have Failed Standard Therapy Stem Cell Mobilization
Status: Not yet active
Phase: No phase specified
Type: Treatment
Age: 18 to 78
Trial IDs: AMD3100-CUP001, NCI-2009-01208, NCT00291811
Start Over